Early-Onset Cyclophosphamide-Induced Interstitial Pneumonitis

JAMA: The Journal of the American Medical Association

Volumn 242, Issue 26, 1979, Pages 2852-2854

  Spector, Jesse I ^a   Zimbler, Harvey ^a   Ross, Jeffrey S ^b  

^a Department of Medicine   (United States)

^b BERKSHIRE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE; CEFALOTIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GENTAMICIN; LOMUSTINE; MELPHALAN; PREDNISONE; PROCARBAZINE; VINCRISTINE; VINCRISTINE SULFATE;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; CASE REPORT; DIAGNOSIS; DRUG INDUCED DISEASE; HISTOLOGY; INTERSTITIAL PNEUMONIA; LYMPHOHISTIOCYTOSIS; ORAL DRUG ADMINISTRATION; RESPIRATORY SYSTEM; THERAPY;

CASE REPORT; CYCLOPHOSPHAMIDE; HUMAN; LUNG; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGE; PULMONARY FIBROSIS;

EID: 0018572670     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1979.03300260022020     Document Type: Article

References (20)

1. Luna MA, Bedrossian CWM, Lichtiger B, et al: Interstitial pneumonitis associated with bleomycin therapy. Am J Clin Pathol 58:501-510, 1972.
2. Clarysse AM, Cathey WJ, Cartwright GE, et al: Pulmonary disease complicating intermittent therapy with methotrexate. JAMA 209:1861-1864, 1969.
3. Selker RG, Jacobs SA, Moore P: Interstitial pulmonary fibrosis as a complication of 1,3-bis-(2-chlorethyl)-1-nitrosourea (BCNU) therapy. Proc Am Assoc Cancer Res and Am Soc Clin Oncology 19:333, 1978.
4. Podoll LN, Winkler SS: Busulfan lung. Am J Roentgenol 120:151-156, 1974.
5. Cole SR, Myers TJ, Klatsky AV: Pulmonary disease with chlorambucil therapy. Cancer 41:455-459, 1978.
6. Taetle R, Dickman PS, Feldman PS: Pulmonary histopathologic changes associated with melphalan therapy. Cancer 42:1239-1245, 1978.
7. Dohner VA, Ward HP, Standord RE: Alveolitis during procarbazine, vincristine and cyclophosphamide therapy. Chest 62:63-69, 1972.
8. Patel AR, Shah PC, Rhee HL, et al: Cyclophosphamide therapy and interstitial pulmonary fibrosis. Cancer 38:1542-1549, 1976.
9. Sostman HD, Matthay RA, Putman CE: Cytotoxic drug-induced lung disease. Am J Med 62:608-615, 1977.
10. Rosenow EC III: The spectrum of drug-induced pulmonary disease. Ann Intern Med 77:977-991, 1972.
11. Andre R, Rochant H, Dreyfus B: Fibrose interstitielle diffuse du poumon au cours d' une maladie de Hodgkin traitee par des doses elevees d' endoxan. Bull Soc Med Hop 118:1133-1141, 1967.
12. Karnofsky DA: Late effects of immunosuppressive anticancer drugs. Fed Proc 26:925-932, 1967.
13. Meschan I, DeArmas CR, Scharyj M: Adult bronchopulmonary dysplasia—the similarity in roentgen and histopathologic appearance between some cases of oxygen toxicity, radiation pneumonitis, and postcytotoxic nonspecific bronchopneumonia. Radiology 92:612-615, 1969.
14. Case 26-1972, Case records of the Massachusetts General Hospital. N Engl J Med 286:1405-1411, 1972.
15. Rodin AE, Haggard ME, Travis LB: Lung changes and chemotherapeutic agents in childhood. Am J Dis Child 120:337-340, 1970.
16. Topilow AA, Rothenberg SP, Cottrell TS: Interstitial pneumonia after prolonged treatment with cyclophosphamide. Am Rev Respir Dis 108:114-117, 1973.
17. Stutz FH, Tormey DC, Bloom J: Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinoma. Can Med Assoc J 108:710-714, 1973.
18. Krakoff I: Bleomycin activity in lymphomas and solid tumors, in Soper WT, Gott AB (eds): New Drug Seminar on Bleomycin. Bethesda, Md, National Cancer Institute, 1974, pp 82-96.
19. Case 12-1978, Case records of the Massachusetts General Hospital. N Engl J Med 298:729-736, 1978.
20. Mark GJ, Lebingar-Zadeh A, Ragsdale BD: Cyclophosphamide pneumonitis. Thorax 33:89-93, 1978.